Internal Medicine, Infectious Disease · Bedford, TX
NPI
1467424812
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2636 Tibbets Dr Ste 110
Bedford, TX, 76022
Phone (817) 858-0065
Groups this clinician bills Medicare through
Medicare paid, 2024
$340K
461,686 services
Medicare patients, 2024
434
Average age 75
Drug cost, 2024
$301K
1,391 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meenakshi Prabhakar was code J0878 (injection, daptomycin, 1 mg), 296,556 times for 23 patients. In total Meenakshi Prabhakar billed 461,686 services in 35 codes, and Medicare paid $340K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 296,556 | 23 | $0.04 | $11K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 3,304 | 26 | $0.36 | $1,180 |
| 96365 Intravenous Infusion, Hydration | Office | 1,107 | 52 | $45.35 | $50K |
| 99214 Office E&M - Established | Office | 537 | 159 | $93.25 | $50K |
| 96367 Intravenous Infusion, Hydration | Office | 467 | 20 | $20.85 | $9,739 |
| 99232 Hospital E&M - Subsequent | Facility | 412 | 190 | $57.82 | $24K |
| 99213 Office E&M - Established | Office | 333 | 102 | $66.70 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 153 | 95 | $86.95 | $13K |
| 99231 Hospital E&M - Subsequent | Facility | 107 | 84 | $36.28 | $3,882 |
| 99222 Hospital E&M - Initial | Facility | 84 | 81 | $96.34 | $8,092 |
| 99204 Office E&M - New | Office | 74 | 72 | $122.76 | $9,084 |
| 99223 Hospital E&M - Initial | Facility | 67 | 66 | $127.60 | $8,549 |
| 99215 Office E&M - Established | Office | 39 | 33 | $132.58 | $5,170 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 32 | 23 | $77.16 | $2,469 |
| 99291 Critical Care E&M | Facility | 23 | 18 | $156.01 | $3,588 |
By year: 2022 $161K for 414,901 services; 2023 $269K for 555,677 services; 2024 $340K for 461,686 services.
Medicare prescription drug claims, 2024
In 2024, the drug Meenakshi Prabhakar prescribed most often to Medicare patients was Daptomycin, with 210 prescriptions and refills. In total Meenakshi Prabhakar wrote 1,391 Medicare prescriptions that cost $301K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 210 | 210 | 36 | $166K |
| Ceftriaxone Ceftriaxone Sodium | 154 | 154 | 27 | $9,576 |
| Doxycycline Hyclate Generic | 144 | 161 | 74 | $3,308 |
| Meropenem Generic | 129 | 129 | 22 | $27K |
| Cefepime Hcl Generic | 107 | 107 | 19 | $18K |
| Vancomycin Hcl Generic | 93 | 93 | 22 | $13K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 46 | 46 | 24 | $948 |
| Levofloxacin Generic | 40 | 42 | 23 | $232 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 39 | 39 | 23 | $216 |
| Ciprofloxacin Hcl Generic | 33 | 34 | 24 | $410 |
| Amoxicillin Generic | 31 | 31 | Under 11 | $766 |
| Diphenhydramine Hcl Generic | 28 | 28 | 22 | $342 |
| Ertapenem Ertapenem Sodium | 24 | 24 | Under 11 | $8,811 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 24 | 24 | Under 11 | $5,400 |
| Fluconazole Generic | 23 | 23 | 18 | $344 |
Brand drugs: 45 claims; generic drugs: 1,346 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Meenakshi Prabhakar were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.